{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:24:45Z","timestamp":1792103085025,"version":"4.4.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T00:00:00Z","timestamp":1732320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["1R16GM145586"],"award-info":[{"award-number":["1R16GM145586"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024065","name":"OM Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.biopha.2024.117710","type":"journal-article","created":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T02:56:24Z","timestamp":1733108184000},"page":"117710","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["OM-85 attenuates high-fat diet-induced obesity, insulin resistance, gut dysbiosis and nonalcoholic steatohepatitis in a murine model"],"prefix":"10.1016","volume":"181","author":[{"given":"Sarah","family":"Hewady","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarence R.","family":"Manuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Pasquali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagadish","family":"Koya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra E.","family":"Reznik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2024.117710_bib1","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/nature05482","article-title":"Mechanisms linking obesity to insulin resistance and type 2 diabetes","volume":"444","author":"Kahn","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2024.117710_bib2","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0140-6736(14)60892-8","article-title":"Body-mass index and risk of 22 specific cancers: a population-based cohort study of 24 million UK adults","volume":"384","author":"Bhaskaran","year":"2014","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.biopha.2024.117710_bib3","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1001\/archgenpsychiatry.2010.2","article-title":"Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies","author":"Luppino","year":"2010","journal-title":"Arch. Gen. Psych."},{"key":"10.1016\/j.biopha.2024.117710_bib4","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1471-2458-9-88","article-title":"The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis","volume":"9","author":"Guh","year":"2009","journal-title":"BMC Public Health"},{"key":"10.1016\/j.biopha.2024.117710_bib5","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1001\/archinte.162.16.1867","article-title":"Overweight and obesity as determinants of cardiovascular risk: the Framingham experience","volume":"162","author":"Wilson","year":"2002","journal-title":"Arch. Int Med"},{"key":"10.1016\/j.biopha.2024.117710_bib6","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults","volume":"348","author":"Calle","year":"2003","journal-title":"N. Eng. J. Med"},{"key":"10.1016\/j.biopha.2024.117710_bib7","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1001\/archneur.62.10.1556","article-title":"Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease","volume":"62","author":"Kivipelto","year":"2005","journal-title":"Arch. Neurol."},{"issue":"2","key":"10.1016\/j.biopha.2024.117710_bib8","doi-asserted-by":"crossref","DOI":"10.1097\/MOL.0000000000000154","article-title":"The immunity-diet-microbiota axis in the development of metabolic syndrome","volume":"26","author":"Brandsma","year":"2015","journal-title":"Curr. Opin. Lipid"},{"key":"10.1016\/j.biopha.2024.117710_bib9","first-page":"515","article-title":"Influence of high-fat diet on gut microbioata: a driving force for chronic disease risk","volume":"18","author":"Murphy","year":"2015","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.biopha.2024.117710_bib10","doi-asserted-by":"crossref","first-page":"E5934","DOI":"10.1073\/pnas.1612559113","article-title":"High-fat diet modifies the PPAR-\u03b3 pathway leading to disruption of microbial and physiological ecosystem in murine small intestine.","volume":"113","author":"Tomas","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2024.117710_bib11","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1080\/19490976.2016.1270811","article-title":"Western diets, gut dysbiosis, and metabolic disease: are they linked?","volume":"8","author":"Martinez","year":"2017","journal-title":"Gut Microbes"},{"key":"10.1016\/j.biopha.2024.117710_bib12","doi-asserted-by":"crossref","first-page":"596.e1","DOI":"10.1016\/j.ajog.2019.02.028","article-title":"Immune tolerance attenuates gut dysbiosis, dysregulated uterine gene expression and high-fat diet potentiated preterm birth in mice","volume":"220","author":"Manuel","year":"2019","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.biopha.2024.117710_bib13","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2147\/DMSO.S146339","article-title":"Obesity and nonalcoholic fatty liver disease: current perspectives","volume":"11","author":"Sarwar","year":"2018","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"10.1016\/j.biopha.2024.117710_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph16061065","article-title":"Impact of OM-85 given during two consecutive years to children with a history of recurrent respiratory tract infections: a retrospective study","volume":"16","author":"Esposito","year":"2019","journal-title":"Int J. Environ. Res Public Health"},{"key":"10.1016\/j.biopha.2024.117710_bib15","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13052-018-0569-7","article-title":"Evidence that a primary anti-viral stimulation of the immune response by OM-85 reduces susceptibility to a secondary respiratory bacterial infection in mice","volume":"44","author":"Rossi","year":"2018","journal-title":"Ital. J. Pedia"},{"key":"10.1016\/j.biopha.2024.117710_bib16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s12519-010-0001-x","article-title":"OM-85 BV, an immunostimulant in pediatric recurrent respiratory tract infections: a systematic review","volume":"6","author":"Schaad","year":"2010","journal-title":"World J. Pedia"},{"key":"10.1016\/j.biopha.2024.117710_bib17","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.intimp.2017.10.032","article-title":"Broncho-Vaxom in pediatric recurrent respiratory tract infections: a systematic review and meta-analysis","volume":"54","author":"Yin","year":"2018","journal-title":"Int Immunopharmacol."},{"key":"10.1016\/j.biopha.2024.117710_bib18","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1378\/chest.122.6.2042","article-title":"BV-child study group. Immunostimulation with OM-85 in children with recurrent infections of the upper respiratory tract: a double-blind, placebo-controlled multicenter study","volume":"122","author":"Schaad","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.biopha.2024.117710_bib19","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s12967-019-2040-y","article-title":"A randomized, placebo-controlled, double-blinded, single-centre phase IV trial to assess the efficacy and safety of OM-85 in children suffering from recurrent respiratory tract infections","volume":"17","author":"Esposito","year":"2019","journal-title":"J. Transl. Med"},{"issue":"1","key":"10.1016\/j.biopha.2024.117710_bib20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/mi.2010.43","article-title":"Boosting airway T-regulatory cells by gastrointestinal stimulation as a strategy for asthma control","volume":"4","author":"Strickland","year":"2011","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.biopha.2024.117710_bib21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3389\/fmed.2014.00041","article-title":"Enhanced mucosal antibody production and protection against respiratory infections following an orally administered bacterial extract","volume":"1","author":"Pasquali","year":"2014","journal-title":"Front Med"},{"issue":"11","key":"10.1016\/j.biopha.2024.117710_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188010","article-title":"Broncho-vaxom (OM-85) modulates rhinovirus docking proteins on human airway epithelial cells via Erk1\/2 mitogen activated protein kinase and cAMP","volume":"12","author":"Roth","year":"2017","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.biopha.2024.117710_bib23","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/mi.2016.85","article-title":"Protection against maternal infection-associated fetal growth restriction: proof-of-concept with a microbial-derived immunomodulator","volume":"10","author":"Scott","year":"2017","journal-title":"Mucosal Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2024.117710_bib24","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/ACI.0000000000000433","article-title":"Non-specific immunomodulators for recurrent respiratory tract infections, wheezing and asthma in children: A systematic review of mechanistic and clinical evidence","volume":"18","author":"Esposito","year":"2018","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"10.1016\/j.biopha.2024.117710_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/srep43844","article-title":"OM-85 is an immunomodulator of interferon-\u03b2 production and inflammasome activity","volume":"7","author":"Dang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2024.117710_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082867","article-title":"Selective activation of human dendritic cells by OM-85 thorugh a NF-kB and MAPK dependent pathway","author":"Parola","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.biopha.2024.117710_bib27","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2337\/diabetes.55.01.06.db05-0189","article-title":"Transforming growth factor-beta and natural killer T-cells are involved in the protective effect of a bacterial extract on type 1 diabetes","volume":"55","author":"Alyanakian","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2024.117710_bib28","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1203\/PDR.0b013e3181b33375","article-title":"Maternal substrate utilization programs the development of the metabolic syndrome in male mice exposed to high fat in utero","volume":"66","author":"Hartil","year":"2009","journal-title":"Pedia Res"},{"issue":"1","key":"10.1016\/j.biopha.2024.117710_bib29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/MCG.0b013e3181dd1348","article-title":"Generalizability of the nonalcoholic steatohepatitis clinical research network histologic scoring system for nonalcoholic fatty liver disease","volume":"45","author":"Juluri","year":"2011","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.biopha.2024.117710_bib30","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1499-3872(17)60019-5","article-title":"Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease","volume":"16","author":"Shen","year":"2017","journal-title":"Hetatob Pancreat. Dis. Int"},{"key":"10.1016\/j.biopha.2024.117710_bib31","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3390\/microorganisms8040573","article-title":"The controversial role of human gut lachnospiraceae","author":"Vacca","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/j.biopha.2024.117710_bib32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"Goto S. KEGG: Kyoto encyclopedia of genes and genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.biopha.2024.117710_bib33","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.metabol.2015.11.008","article-title":"Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"65","author":"Brown","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.biopha.2024.117710_bib34","article-title":"Liver fibrosis in non-alcoholic fatty liver disease: from liver biopsy to non-invasive biomarkers in diagnosis and treatment","volume":"14","author":"Heyens","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.biopha.2024.117710_bib35","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nature18846","article-title":"Diet-microbiota interactions as moderators of human metabolism","volume":"535","author":"Sonnenburg","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2024.117710_bib36","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1126\/science.1110591","article-title":"Diversity of the human intestinal microbial flora","volume":"308","author":"Eckburg","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.biopha.2024.117710_bib37","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nature11234","article-title":"The Human Microbiome Consortium. Structure, function and diversity of the healthy human microbiome","volume":"486","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2024.117710_bib38","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/4441022a","article-title":"Microbial ecology: human gut microbes associated with obesity","volume":"444","author":"Ley","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2024.117710_bib39","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/ismej.2013.155","article-title":"High-fat diet alters gut microbiota physiology in mice","volume":"8","author":"Daniel","year":"2014","journal-title":"ISME J."},{"key":"10.1016\/j.biopha.2024.117710_bib40","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1038\/s41598-018-22094-2","article-title":"Xiexin Tang improves the symptom of type 2 diabetic rats by modulation of the gut microbiota","volume":"8","author":"Wei","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2024.117710_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EC-15-0094","article-title":"Gut microbiota and diet in patients with different glucose tolerance","volume":"5","author":"Egshatyan","year":"2016","journal-title":"Endocr. Connect"},{"key":"10.1016\/j.biopha.2024.117710_bib42","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1099\/ijs.0.036541-0","article-title":"Blautia hominis sp. nov., isolated from human faeces","volume":"63","author":"Shin","year":"2013","journal-title":"Int J. Syst. Evol. Microbiol"},{"key":"10.1016\/j.biopha.2024.117710_bib43","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1136\/gutjnl-2014-306928","article-title":"Microbiota and diabetes: an evolving relationship","volume":"63","author":"Tilg","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.biopha.2024.117710_bib44","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1136\/gutjnl-2012-303839","article-title":"An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice","volume":"63","author":"Shin","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.biopha.2024.117710_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/nu12041082","article-title":"Gut microbiome, intestinal permeability, and tissue bacteria in metabolic disease: Perpetrators or bystanders?","volume":"12","author":"Chakaroun","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2024.117710_bib46","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3164\/jcbn.18-57","article-title":"A next-generation beneficial microbe: Akkermensia mucinophila","volume":"63","author":"Naito","year":"2018","journal-title":"J. Clin. Biochem Nutr."},{"key":"10.1016\/j.biopha.2024.117710_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2020.111237","article-title":"Long-term hexavalent chromium exposure facilitates colorectal cancer in mice associated with changes in gut microbiota composition","volume":"138","author":"Zhang","year":"2020","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.biopha.2024.117710_bib48","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nature13793","article-title":"Artificial sweeteners induce glucose intolerance by altering the gut microbiota","volume":"514","author":"Suez","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2024.117710_bib49","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12866-019-1494-7","article-title":"Changes in the gut microbiome and fermentation products concurrent with enhanced longevity in acarbose-treated mice","volume":"19","author":"Smith","year":"2019","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.biopha.2024.117710_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/nature05414","article-title":"An obesity-associated gut microbiome with increased capacity for energy harvest","volume":"444","author":"Turnbaugh","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2024.117710_bib51","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/978-1-61779-430-8_27","article-title":"A mouse model of diet-induced obesity and insulin resistance","volume":"821","author":"Wang","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.biopha.2024.117710_bib52","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/oby.2007.608","article-title":"High-fat diets: modeling the metabolic disorders of human obesity in rodents","volume":"15","author":"Buettner","year":"2007","journal-title":"Obes. (Silver Spring)"},{"key":"10.1016\/j.biopha.2024.117710_bib53","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/s41423-021-00780-y","article-title":"Impact of intracellular innate immune receptors on immunometabolism","volume":"19","author":"Chou","year":"2022","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.biopha.2024.117710_bib54","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/imr.12858","article-title":"Immunometabolism: from basic mechanisms to translation","volume":"295","author":"Makowski","year":"2020","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.biopha.2024.117710_bib55","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.cell.2015.02.022","article-title":"Immune regulation of metabolic homeostasis in health and disease","volume":"161","author":"Brestoff","year":"2015","journal-title":"Cell"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224015968?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224015968?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:01:03Z","timestamp":1787922063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224015968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":55,"alternative-id":["S0753332224015968"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117710","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"OM-85 attenuates high-fat diet-induced obesity, insulin resistance, gut dysbiosis and nonalcoholic steatohepatitis in a murine model","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117710","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117710"}}